HSA — authorised 21 January 1987
- Marketing authorisation holder: BRACCO
- Status: likely_approved
HSA authorised Choletec on 21 January 1987
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 21 January 1987.
BRACCO holds the Singaporean marketing authorisation.